Recombinant Human monoclonal Single Domain Antibody expressed in E. coli binding to Human KCNA3. The anti-Kv1.3 single domain antibodies, something that has historically been difficult to achieve with other drug modalities such as small molecules and peptide-based toxins. The Kv1.3 ion channel represents an important target in inflammatory disease as it helps control ion influx required for activation of T lymphocytes.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-0634CL | Human Anti-KCNA3 Recombinant Antibody (TAB-0634CL) | ELISA | Humanized IgG |
TAB-0634CL-S(P) | Human Anti-KCNA3 Recombinant Antibody; scFv Fragment (TAB-0634CL-S(P)) | ELISA | Humanized scFv |
TAB-0634CL-F(E) | Human Anti-KCNA3 Recombinant Antibody; Fab Fragment (TAB-0634CL-F(E)) | ELISA | Humanized Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-2301CT | Recombinant Mouse anti-Human KCNA3 Monoclonal antibody (FQS5599) | WB, IHC-P, IHC-Fr, ICC/IF |
There are currently no Customer reviews or questions for TAB-466CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.